Top 50 Medical Device VC Funds & Investors in Germany (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
HTGF (High-Tech Gruenderfonds)
VC Fund
|
22 | Germany, Switzerland, United States | Seed, Series A | Software, Biotechnology, Information Technology | $909k–$33M |
|
Bayern Kapital
VC Fund
|
10 | Germany, United States, Finland | Seed, Series A | Software, Health Care, Information Technology | $1.1M–$31M |
|
NRW.BANK
VC Fund
|
7 | Germany, United States, France | Seed, Series A, Series B | Information Technology, Software, Biotechnology | $110k–$71M |
|
KfW
VC Fund
|
7 | Germany, India, Kenya | Series A, Series B | Biotechnology, Software, Health Care | $2.2M–$17M |
|
TGFS - Technologiegründerfonds Sachsen
VC Fund
|
6 | Germany, United States | Seed, Series A | Software, Information Technology, Manufacturing | $932k–$15M |
|
bm-t beteiligungsmanagement thuringen
VC Fund
|
5 | Germany, United States | Seed, Series A | Software, Information Technology, Health Care | $461k–$18M |
|
MIG Capital
VC Fund
|
5 | Germany, France, Austria | Series A, Series B | Biotechnology, Health Care, Therapeutics | $1.6M–$54M |
|
bmp Ventures
VC Fund
|
5 | Germany, United States, Austria | Seed, Series A | Software, Information Technology, Manufacturing | $30k–$5.9M |
|
Brandenburg Kapital
VC Fund
|
5 | Germany, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $823k–$14M |
|
Expon Capital
VC Fund
|
4 | Luxembourg, France, United States | Seed, Series A, Series B | Software, E-Commerce, Financial Services | $635k–$54M |
|
Playground Global
VC Fund
|
3 | United States, Canada, Italy | Series A, Series B, Seed | Software, Robotics, Biotechnology | $2.2M–$153M |
|
11k Ventures
VC Fund
|
3 | Germany, United States | Seed, Pre-Seed, Convertible Note | Health Care, Medical Device, Artificial Intelligence | $637k–$3M |
|
S-Venture Capital Dortmund
VC Fund
|
3 | Germany | Series B, Series A | Biotechnology, Guides, Genetics | $3.6M–$9M |
|
Sparrow Ventures
VC Fund
|
3 | Switzerland, Finland, Germany | Series A, Seed | Health Care, Real Estate, Medical Device | $3.3M–$8.2M |
|
Hevella Capital
VC Fund
|
3 | Germany, Canada, Austria | Seed, Series A | FinTech, Software, E-Commerce | $2.2M–$7.4M |
|
HealthCap
VC Fund
|
3 | United States, Sweden, France | Series B, Series A | Biotechnology, Health Care, Medical | $5.7M–$88M |
|
MassMutual Ventures
VC Fund
|
3 | United States, India, Singapore | Series A, Series B, Seed | Software, Financial Services, Information Technology | $2.5M–$40M |
|
Heal Capital
VC Fund
|
3 | Germany, United Kingdom, France | Seed, Series A, Pre-Seed | Health Care, Artificial Intelligence, Machine Learning | $1M–$33M |
|
IFB Innovationsstarter
VC Fund
|
3 | Germany, United States | Seed, Grant | Software, SaaS, Artificial Intelligence | $80k–$3M |
|
Born2Grow
VC Fund
|
3 | Germany, Finland, United States | Seed, Series A, Series B | Software, Medical, Health Care | $1.1M–$3.3M |
|
Sofinnova Partners
VC Fund
|
3 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $6M–$102M |
|
Think.Health
VC Fund
|
3 | Germany, United States, France | Seed, Series A, Series B | Health Care, Biotechnology, Medical Device | $1.1M–$28M |
|
SOSV
VC Fund
|
3 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
Sparkasse Jena
VC Fund
|
2 | Germany, United States | Seed, Series A, Series C | Medical, Health Care, Shopping | |
|
Carma Fund
VC Fund
|
2 | Germany, France, Sweden | Seed, Series A, Series B | Health Care, Biotechnology, Medical Device | $2.7M–$62M |
|
Wellington Partners
VC Fund
|
2 | Germany, United States, United Kingdom | Series A, Series B | Health Care, Biotechnology, Medical | |
|
Bertelsmann Investments
VC Fund
|
2 | Germany, United States, Israel | Series A, Series B, Seed | Health Care, Medical, Artificial Intelligence | $3M–$33M |
|
ES KAPITAL
VC Fund
|
2 | Germany | Seed, Pre-Seed, Series A | Software, EdTech, Medical | $1.2M–$30M |
|
APEX Ventures
VC Fund
|
2 | Germany, United Kingdom, Austria | Seed, Series A, Pre-Seed | Artificial Intelligence, Software, Health Care | $511k–$28M |
|
Atlantic
VC Fund
|
2 | Germany, Switzerland, United States | Seed, Pre-Seed, Series A | Software, Health Care, Financial Services | $850k–$32M |
|
BayBG Venture Capital
VC Fund
|
2 | Germany, Italy, United States | Series A, Series B | Software, Information Technology, Health Care | $428k–$23M |
|
Seed Fonds Aachen
VC Fund
|
2 | Germany | Seed, Series A | Biotechnology, Medical, Health Care | $2.2M–$6M |
|
AQAL Integral Investing
VC Fund
|
2 | Germany, United States | Seed, Pre-Seed | Health Care, Medical Device, Medical | |
|
TruVenturo
VC Fund
|
2 | Germany, United States, Spain | Seed, Series A | Travel, Tourism, Software | $1.1M–$26M |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
2 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.3M–$50M |
|
DocCheck Guano AG
VC Fund
|
2 | Germany, Spain, The Netherlands | Seed, Pre-Seed | Health Care, Medical, Mobile Apps | |
|
American RENOLIT Corporation
VC Fund
|
2 | Germany | Series A | Health Care, Medical Device, 3D Printing | |
|
Entrée Capital
VC Fund
|
2 | United States, Israel, United Kingdom | Seed, Series A, Series B | Software, FinTech, Financial Services | $1.4M–$55M |
|
Asabys Partners
VC Fund
|
2 | Spain, France, Belgium | Series A, Series B, Seed | Health Care, Biotechnology, Medical Device | $1.2M–$55M |
|
The TQ Group
VC Fund
|
2 | Germany | Seed, Series A, Series B | Sports, Hardware, Robotics | |
|
Lauder Partners
VC Fund
|
2 | United States, United Kingdom, China | Series B, Seed | Software, Internet, Health Care | $300k–$50M |
|
M-Invest
VC Fund
|
2 | Germany | Series A | Medical Device, Medical, Software | |
|
Winning Mindset Ventures
VC Fund
|
2 | Germany | Series A | Medical, Software, Consulting | $13M–$13M |
|
b2venture
VC Fund
|
2 | Germany, Switzerland, United Kingdom | Series A, Seed, Series B | Software, Health Care, Information Technology | $1.3M–$52M |
|
TechVision Fund
VC Fund
|
2 | Germany, Spain | Seed, Series A, Pre-Seed | Software, Health Care, Manufacturing | $2.5M–$28M |
|
Green Park & Golf Ventures
VC Fund
|
2 | United States, Israel, Sweden | Series A, Seed, Series B | Health Care, Medical, Biotechnology | $420k–$45M |
|
YZR Capital
VC Fund
|
2 | Germany, Poland, United Kingdom | Seed, Pre-Seed, Series A | Health Care, Software, Artificial Intelligence | $764k–$48M |
|
IBG Beteiligungsgesellschaft Sachsen-Anhalt
VC Fund
|
2 | Germany, Austria | Seed, Series A | Software, Electronics, Manufacturing | $1.3M–$5.9M |
|
Grönemeyer Swiss Health
VC Fund
|
1 | Germany | Series A | Medical, Manufacturing, Medical Device | |
|
dRx Capital
VC Fund
|
1 | United States, Germany, United Kingdom | Series B, Series C, Series A | Health Care, Biotechnology, Medical | $3M–$160M |
| Access all 265 VC funds in Germany Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 542
- Round size: Seed $909k–$6.5M; Series A $3M–$33M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely still investing — raised $522M in 2022
Portfolio highlights
- Sdui — Sdui is the solution for mobile communication in schools. With amazingly easy features for messaging, timetables and a wide range of third party integrations, the app digitizes processes and reduces administrative effort. Within two years, Sdui has reached hundreds of institutions and grown a serious reputation in the educational market.
- envelio — We are driving forward the energy transition with our smart grid solutions for grid operators. Get information now and plan smart!
- Atriva Therapeutics — Therapies against viral infections. First-in-class host-targeting therapies to treat respiratory viral infections, including COVID-19 and influenza.
Bayern Kapital (founded at the end of 1995) is a wholly owned subsidiary of the LfA Foerderbank Bayern (Bavaria‘s development bank). Bayern Kapital’s objective is to finance research and development as well as the market launch of new products, product diversifications, and expansion of the market share.The requesting company has to be located inBavaria. Industries are e. g. IT/software, life sciences, new materials, micro-systems and environmental technologies.Bayern Kapital and its funds have invested in more than 250 companies and currently manages funds to the value of EUR 340 m. The five investing funds currently managed by Bayern Kapital are Seedfonds Bayern, Clusterfonds Start-Up!, Innovationsfonds, Innovationsfonds EFRE and Wachstumsfonds Bayern.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: Germany, United States, Finland
Investor stats
- Total investments: 227
- Round size: Seed $1.1M–$5.5M; Series A $3.9M–$31M
- Lead/follow: 15% lead, 85% follow
- Last fund: May invest from a new fund soon — raised $26M in 2010
Portfolio highlights
- EcoG — EcoG connects and enables monetizing charging infrastructure with an API-software platform. EcoG is the first cloud-based platform to enable shared revenue streams and value-added services in fast charging. With EcoG a personalized and customized EV fast charging experience is easy to implement and operate.
- XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
- inContAlert — inContAlert is a deep tech start-up disrupting the field of incontinence. The technology of inContAlert helps people with bladder dysfunction to monitor the filling level of their urinary bladder.inContAlert, therefore, developed an mHealth device, which collects and analyzes data with the help of deep learning algorithms. The information is thendisplayed on an app and sends an alert to incontinence patients when a predefined filling level is reached. inContAlert thereby minimizes the risk of an uncontrolled loss of urine or the harmful distension of the bladder. With the help of inContAlert, incontinence patients can go back to normal and live a carefree life.
NRW.BANK is the development bank for the state of North Rhine-Westphalia. It supports its owner – the state of North Rhine-Westphalia – in fulfilling its tasks, notably in the fields of structural, economic, social and housing policy. NRW.BANK pools the promotion and development programmes of the state of North Rhine-Westphalia, the FederalRepublic of Germany and the European Union and combines them with its own equity and debt products and advisory services. It offers the full range of financial products in three areas “Economy”, “Housing”, and “Infrastructure/Municipalities”. NRW.BANK operates in a competitively neutral manner as a partner of banks and savings banks.
Show more...Investment focus
- Industry: Information Technology, Software, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: Germany, United States, France
Investor stats
- Total investments: 119
- Round size: Seed $110k–$7.7M; Series A $3.8M–$33M; Series B $3.8M–$71M
- Lead/follow: 21% lead, 79% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- odacova — Odacova is a SaaS company that provides individualized nutrition for corporate cafeterias and employee eating, utilizing web, Android, and iOS platforms.
- eleQtron — eleQtron creates and operates quantum computers based on trapped ions, radio frequency control, and Magnetic Gradient Induced Coupling (MAGIC). It also puts forward novel ideas for scalable quantum processors based on RF-controlled trapped ions. eleQtron will run MAGIC quantum computers and provide quantum computing performance on a subscriptionbasis.
- Cellbox Solutions — Cellbox Solutions is a young technology company that focuses on innovative logistic solutions for the global BioMed industry.
KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the Länder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sizedenterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Series A, Series B
- Geography: Germany, India, Kenya
Investor stats
- Total investments: 140
- Round size: Series A $2.2M–$7.7M; Series B $3.3M–$17M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Vectoflow — Vectoflow is an innovative company developing fluid-dynamic metrology devices for fluid flow and dynamics measurement. It offers standardized and customized flow measurement technology that measures the static and total pressure, velocity, and angle of attack of a flow. These products are used in motorsport, aviation, turbine machine development,and research sectors.
- Electrochaea — Electrochaea is commercializing a disruptive, scalable technology to convert electric power into methane, the principal component of natural gas. Using CO2 as a feedstock gas, power can be efficiently converted to renewable natural gas for power storage, for transportation fuels, or for transmission via a natural gas network. The company licensedtechnology from the University of Chicago and is led by the Nidus Partners, a St. Louis investment group specializing in renewable energy. Mich Hein, a Nidus Managing Partner, serves as CEO.Electrochaea has developed a commercially viable and disruptive solution for utility-scale energy storage, grid balancing, and carbon reuse. Their proprietary process converts low-cost and stranded electricity and carbon dioxide into pipeline-grade renewable gas for direct injection into the existing natural gas grid, a conversion process known as “power-to-gas”.
- CryoTherapeutics — CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intendsto extend the benefits of cryoenergy to the problem of diseased coronary arteries.
TGFS - Technologiegruenderfonds Sachsen is an early stage VC fund targeting high tech startups with strong growth potential. The fund invests into ventures located in Saxony/Germany, Europe's leading semiconductor cluster. The team has invested into more than 120 companies so far, including more than 40 investments from the currentfund.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Seed, Series A
- Geography: Germany, United States
Investor stats
- Total investments: 137
- Round size: Seed $932k–$4.8M; Series A $1.9M–$15M
- Lead/follow: 23% lead, 77% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Peeriot — Peeriot is a B2B software high-tech startup with a breakthrough in IoT. Peeriot offers a low-code software suite that simplifies IoT data sharing by tenfold.
- Primogene —
- b.sure — b.sure help brands, agencies and event organizers to make their offline events as measurable as their online marketing.
bm|t supports innovative and growth-oriented companies in Thuringia with equity investments and venture capital.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Germany, United States
Investor stats
- Total investments: 61
- Round size: Seed $461k–$7M; Series A $1.1M–$18M
- Lead/follow: 64% lead, 36% follow
Portfolio highlights
- Leapter — Leapter is the trust engine for AI agents. Build logic tools for AI Agents and de-risk your AI workflows with visual, executable blueprints for deterministic decisions.
- Peeriot — Peeriot is a B2B software high-tech startup with a breakthrough in IoT. Peeriot offers a low-code software suite that simplifies IoT data sharing by tenfold.
- warmwind — warmwind operates as an AI operating system for visual process automation.
MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These fundsoperate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria.Today, our portfolio consists of 30 companies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B
- Geography: Germany, France, Austria
Investor stats
- Total investments: 93
- Round size: Series A $2.2M–$28M; Series B $1.6M–$54M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — raised $70M in 2014
Portfolio highlights
- AMSilk — AMSilk produces and distributes high-quality silk biopolymers for use in textile products, medical devices, and cosmetics.
- Look Up Space — Lookup space is the next global leader for space safety, security and sustainability
- ASTRA Therapeutics — Astra - Therapeutics
bmp Ventures is an innovative Venture Capital Company from Berlin. Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Seed, Series A
- Geography: Germany, United States, Austria
Investor stats
- Total investments: 118
- Round size: Seed $151k–$3.4M; Series A $30k–$5.9M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Sedivention — Fight obesity within 20 minutes - fast, effective, long-term. A new weight-loss therapy for the treatment of obesity. Just a view minutes will change your life.
- Solar Materials — SOLAR MATERIALS developed a recycling technology for solar modules, which recovers all raw materials for a circular solar industry.
- Litherm Technologies — Litherm Technologies GmbH is a German deep‑tech startup focused on decarbonizing lime and cement production using fully electric kiln technology.
With a track record of over 20 years in venture capital and experience from more than 200 investments in numerous companies BFB Brandenburg Kapital GmbH (BFB) is the most active equity investor in Brandenburg. BFB invests in fast-growing technology-orientated companies throughout the whole life-cycle. Target sectors are ICT/Digital Economy,Life Science, MedTech, Proptech, Industrial Applications. BFB invests in companies based in or with facilities in Brandenburg. The current VC fund is financed by the European Regional Development Fund (ERDF) an Investitionsbank des Landes Brandenburg (ILB).
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Germany, United Kingdom
Investor stats
- Total investments: 72
- Round size: Seed $823k–$6.1M; Series A $2.7M–$14M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Kupando — Kupando is a biopharmaceutical company that develops agonists to stimulates innate immunity.
- ThinkSono — ThinkSono Guidance enables any non-ultrasound trained healthcare professional to scan for blood clots (DVT). It reduces waiting times, negative DVT cases and can be used at the point of care.
- ALVA Energie — Alva delivers turnkey solar systems with integrated energy, heating, and e-mobility for buildings
Global investor in big ideas with the potential for positive impact & exponential growth
Show more...Investment focus
- Industry: Software, E-Commerce, Financial Services
- Stage:Seed, Series A, Series B
- Geography: Luxembourg, France, United States
Investor stats
- Total investments: 70
- Round size: Seed $635k–$5M; Series A $2.3M–$27M; Series B $16M–$54M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Dott — We believe in a future where cities are pollution-free and designed for people, not cars.
- Coinhouse — Buy Bitcoin, Ethereum and Litecoin on Coinhouse, consult our educational content or visit our physical space, Coinhouse Store. Invest in the future, today.
- nexten.io — nexten.io is the ideal platform for Tech profiles and Developers looking for Remote IT Jobs or IT Jobs in France. Create your Anonymous Profile in minutes; after accepting their requests, CTOs and team leaders of the best tech companies will send opportunities for your next dream job!
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Playground Global is an early-stage venture capital firm backing technical and scientific founders with deep engineering expertise, a collaborative environment, and a first-hand understanding of the intricacies of deep tech. Established in 2015 and headquartered in Palo Alto, CA, Playground’s mission is to transform ambitious ideas into impactfulbusinesses that benefit humanity and the planet. We invest in areas that span across next gen compute automation, energy transition and engineered biology. Playground has been an early – and frequently first investor – in companies that include PsiQuantum, Relativity Space, Ultima Genomics, MosaicML (acq. by Databricks), d-Matrix, and Strand Therapeutics.
Show more...Investment focus
- Industry: Software, Robotics, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: United States, Canada, Italy
Investor stats
- Total investments: 132
- Round size: Seed $2.2M–$20M; Series A $7M–$35M; Series B $20M–$153M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $410M in 2023
Portfolio highlights
- Insamo — Insamo is a global biotechnology company pioneering the discovery of membrane-permeable and orally available cyclic-peptides with antibody-like binding affinity.
- Leaf Logistics — Leaf is building a more transparent industry-wide network that reveals exponentially more opportunities for network coordination. Learn more here.
- Element Zero — Element Zero has developed a novel approach to cost-effectively and efficiently convert metal ores such as iron ore, nickel ore and other future facing metals, to pure metal form with zero carbon emissions.
We are a business angel collective based in Germany. We help early-stage startups that want to make a difference by preservation and improvement of human health.
Show more...Investment focus
- Industry: Health Care, Medical Device, Artificial Intelligence
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: Germany, United States
Investor stats
- Total investments: 6
- Round size: Seed $637k–$3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- DeepSpin — DeepSpin is developing a next-gen, AI-powered MRI machine at a fraction of the cost, size and weight of standard systems, allowing to bring MRI to the point-of-care.
- Mindpeak — Harnessing the power of Artificial Intelligence and machine learning, Mindpeak products can help make pathology diagnosis faster and more accurate.
- atmio — atmio helps natural gas operations to find, fix and report methane emissions easily.
S-Venture Capital Dortmund aims to fund technology companies and is a German regional investment group.
Show more...Investment focus
- Industry: Biotechnology, Guides, Genetics
- Stage:Series B, Series A
- Geography: Germany
Investor stats
- Total investments: 9
- Round size: Series B $3.6M–$9M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Innolume — Innolume has invented a novel comb laser light engine for short-reach optical interconnects between and within computers. Economical wavelength-division multiplexing (WDM) is enabled by this class of low-cost, low-power Fabry-Perot lasers. WDM, familiar from telecom, provides an efficient alternative to multiple lasers and underutilized parallelfiber/waveguides, reducing short-reach system cost and power.
- Protagen — Protagen is a precision medicine specialist that support drug development, facilitate treatment strategies and improve patient management. Protagen is at the forefront of immuno-profiling and the discovery of novel autoantibody signatures for autoimmune disease and immuno-oncology. Protagen’s SeroTag® technology identifies biomarkers that address anumber of challenges currently hindering the successful development and broader application of both cancer immunotherapies and novel treatments for autoimmune diseases.The company is a leader in patient stratification for autoimmune disease, having developed disease-specific NavigAID stratification panels that profile individual patient’s autoimmune condition and immune status. This precision medicine approach allows for the development and implementation of more targeted therapies for diseases such as systemic lupus erythematosus (SLE), systemic sclerosis (SSc), rheumatoid arthritis (RA), Sjögren’s syndrome (SjS) and others.
- Scienion — SCIENION AG is a life science company well positioned in the markets of ultra-low volume liquid handling systems and microarray technologies. They provide their customers with an integrated product portfolio facilitating and improving multiparallel bioanalytics, high throughput screening and high throughput production of microarrays in the genomicsand proteomics fields – from early research to manufacturing.
We are a Zurich-based Venture Builder and Growth Equity Investor. With our ambitious team of highly customer-focused entrepreneurs, we are committed to putting our expertise to work and strive to make an impact.
Show more...Investment focus
- Industry: Health Care, Real Estate, Medical Device
- Stage:Series A, Seed
- Geography: Switzerland, Finland, Germany
Investor stats
- Total investments: 13
- Round size: Seed $6.1M–$7M; Series A $3.3M–$8.2M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- properti — "building the world's greatest real estate company"Properti is a modern, young and pioneering PropTech startup founded in November 2019. Through our unique Properti System, which combines the latest technologies, in-depth expertise and world-class marketing, we provide an exclusive service. Our mission is to change the real estateindustry sustainably with the symbiosis of technology and people to build trustworthiness and transparency. Our goal is to offer customers a full service around the housing ecosystem.
- HelloBetter — HelloBetter (hellobetter.de) was founded in 2015 under the name GET.ON Institut für Online Gesundheitstrainings GmbH (geton-institut.de) by internationally renowned research psychologists, and in close partnership with one of the largest public health care insurance companies in Germany (BARMER). HelloBetter is a pioneer in the field of e-mentalhealth and a leading provider of online mental health courses. Its work has a strong scientific basis – the courses were developed, evaluated, and implemented in a practice setting, and their effectiveness has been proven in 33 randomized controlled trials according to the highest standards of scientific practice. HelloBetter offers the widest range of evidence-based online mental health courses worldwide, with 11 digital courses covering 8 problem areas (stress, depression, insomnia, depression in the case of chronic illness, chronic pain, alcohol consumption, excessive worry, and panic and anxiety).In October 2021, the digital therapeutic 'HelloBetter Stress and Burnout' has been permanently approved by the German Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) and thus is available by prescription free of charge for more than 50 million adults. It is the world’s first and so far only prescription digital therapeutic for the treatment of burnout symptoms.Through diverse cooperations with national and international research groups (including FAU Erlangen, University of Ulm, VU Amsterdam, and Harvard University) HelloBetter finds practical applications for the latest research innovations. Our products and our team have been awarded numerous national and international prizes. These include the Novartis & Sandoz/Hexal Digital Health Prize 2018, the Comenius Award of the European Federation of Psychologists’ Association, and the Good Practice in Mental Health & Wellbeing seal of approval as part of the EU Compass 2018, which recognises high-quality mental health initiatives in Europe in order to guide health care providers to effective and proven services.
- Selma Finance — With Selma you will get an investment plan that fits to your life and goals. Get started in minutes and let your money work for you.
Hevella Capital is a principal investment firm.
Show more...Investment focus
- Industry: FinTech, Software, E-Commerce
- Stage:Seed, Series A
- Geography: Germany, Canada, Austria
Investor stats
- Total investments: 22
- Round size: Seed $2.2M–$3.8M; Series A $3.7M–$7.4M
- Lead/follow: 55% lead, 45% follow
Portfolio highlights
- fulfin — Beantragen Sie Ihre Finanzierung jetzt und wachsen Sie mit Fulfin!
- HelloBetter — HelloBetter (hellobetter.de) was founded in 2015 under the name GET.ON Institut für Online Gesundheitstrainings GmbH (geton-institut.de) by internationally renowned research psychologists, and in close partnership with one of the largest public health care insurance companies in Germany (BARMER). HelloBetter is a pioneer in the field of e-mentalhealth and a leading provider of online mental health courses. Its work has a strong scientific basis – the courses were developed, evaluated, and implemented in a practice setting, and their effectiveness has been proven in 33 randomized controlled trials according to the highest standards of scientific practice. HelloBetter offers the widest range of evidence-based online mental health courses worldwide, with 11 digital courses covering 8 problem areas (stress, depression, insomnia, depression in the case of chronic illness, chronic pain, alcohol consumption, excessive worry, and panic and anxiety).In October 2021, the digital therapeutic 'HelloBetter Stress and Burnout' has been permanently approved by the German Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) and thus is available by prescription free of charge for more than 50 million adults. It is the world’s first and so far only prescription digital therapeutic for the treatment of burnout symptoms.Through diverse cooperations with national and international research groups (including FAU Erlangen, University of Ulm, VU Amsterdam, and Harvard University) HelloBetter finds practical applications for the latest research innovations. Our products and our team have been awarded numerous national and international prizes. These include the Novartis & Sandoz/Hexal Digital Health Prize 2018, the Comenius Award of the European Federation of Psychologists’ Association, and the Good Practice in Mental Health & Wellbeing seal of approval as part of the EU Compass 2018, which recognises high-quality mental health initiatives in Europe in order to guide health care providers to effective and proven services.
- ChargeX — ChargeX provides electric car charging solutions. Tobias Wagner, Michael Masnitza, and Johannes Engeln founded it in 2017, with its headquarters in Munich in Germany.
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: United States, Sweden, France
Investor stats
- Total investments: 121
- Round size: Series A $5.7M–$55M; Series B $14M–$88M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $209M in 2019
Portfolio highlights
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- HelloBetter — HelloBetter (hellobetter.de) was founded in 2015 under the name GET.ON Institut für Online Gesundheitstrainings GmbH (geton-institut.de) by internationally renowned research psychologists, and in close partnership with one of the largest public health care insurance companies in Germany (BARMER). HelloBetter is a pioneer in the field of e-mentalhealth and a leading provider of online mental health courses. Its work has a strong scientific basis – the courses were developed, evaluated, and implemented in a practice setting, and their effectiveness has been proven in 33 randomized controlled trials according to the highest standards of scientific practice. HelloBetter offers the widest range of evidence-based online mental health courses worldwide, with 11 digital courses covering 8 problem areas (stress, depression, insomnia, depression in the case of chronic illness, chronic pain, alcohol consumption, excessive worry, and panic and anxiety).In October 2021, the digital therapeutic 'HelloBetter Stress and Burnout' has been permanently approved by the German Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) and thus is available by prescription free of charge for more than 50 million adults. It is the world’s first and so far only prescription digital therapeutic for the treatment of burnout symptoms.Through diverse cooperations with national and international research groups (including FAU Erlangen, University of Ulm, VU Amsterdam, and Harvard University) HelloBetter finds practical applications for the latest research innovations. Our products and our team have been awarded numerous national and international prizes. These include the Novartis & Sandoz/Hexal Digital Health Prize 2018, the Comenius Award of the European Federation of Psychologists’ Association, and the Good Practice in Mental Health & Wellbeing seal of approval as part of the EU Compass 2018, which recognises high-quality mental health initiatives in Europe in order to guide health care providers to effective and proven services.
- Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
MMV is a multistage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health companies. We help accelerate the growth of the companies we partner with by providing capital, connections and advice.
Show more...Investment focus
- Industry: Software, Financial Services, Information Technology
- Stage:Series A, Series B, Seed
- Geography: United States, India, Singapore
Investor stats
- Total investments: 139
- Round size: Seed $2.5M–$9.3M; Series A $4.4M–$25M; Series B $7M–$40M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $100M in 2022
Portfolio highlights
- SecZetta — SecZetta. We provide third-party identity risk solutions that are easy to use, and purpose built to help organizations execute risk-based identity access and lifecycle strategies for non-employee populations.
- Prove — Prove is the modern way for businesses to enable their customers to prove their identities with just a phone. Prove offers phone-centric solutions that enable its customers to acquire new consumers and engage with their existing consumers by removing friction while bolstering security, and enhancing consumer privacy and consumer choice.Prove's solutions are used by more than 1,000 businesses across diversified industries, including banks, financial services, healthcare, insurance, and e-commerce.Prove has two main solutions + MFA:• Prove Pre-fill™ for Onboarding & Digital Acquisition, which helps companies increase signups and mitigate account opening fraud by authenticating consumer identities, and auto-filling verified data in any channel.• Fonebook™ for Digital Servicing, which helps companies:- Access a single identity authentication platform that reduces complexity and total cost of ownership to create a holistic view of your customer across their entire channels - Manage, add, and update customer phone numbers to ensure you always have the right number for your customerMulti-factor Authentication:- Standard SMS & Voice OTPs - Instant Link™ (authenticate through SMS link without needing OTP) - Mobile Auth™ (authentication via cellular networks; passive method for passwordless login) - Voice Biometrics – Match against a consumer’s voice for authentication - Push Authentication – App-based method to prove Possession, can also pull in behavioral biometrics, device (PKI), and environmental (Wi-Fi, Bluetooth, network) signals - Secure transactions across multiple digital servicing use cases, including login, high-risk transactions, call center, and passwordless login
- Mine — "Mine helps you discover where your personal data is and manage your digital footprint. You decide where your data should or shouldn't be, we'll make it happen. "
Heal Capital is a European venture capital fund backing mission-driven founders with capital and HealthTech-specific expertise, accelerating market access.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United Kingdom, France
Investor stats
- Total investments: 36
- Round size: Seed $1M–$9.5M; Pre-Seed $1.9M–$2.7M; Series A $10M–$33M
- Lead/follow: 50% lead, 50% follow
- Last fund: May invest from a new fund soon — raised $102M in 2020
Portfolio highlights
- Apheris — Superior drug discovery models through federated data networks
- Avi Medical — Avi Medical is a digital health care company that provides telemedicine services. Its platform enables patients to book appointments, manage their health data, and chat with the practitioner. The company uses data-driven medicine to provide patients and healthcare workers with a streamlined, more modern experience.
- LivNao Technologies — LivNao Technologies leverages deep learning to detect changes in mental health before it affects performance and productivity. Their deep learning model can detect deviation before performance is affected by collecting data passively. When they have detected a change in mental health, they nudge individuals with an intervention based on theirhealth plan.LivNao is committed to creating a healthier, happier, and more productive world, in the way they know best using data. LivNao is also 100% HIPAA-compliant. It was based in Vancouver, Canada.
The IFB Innovationsstarter is an innovation funding and investment company of the City of Hamburg providing grants and investments.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Grant
- Geography: Germany, United States
Investor stats
- Total investments: 77
- Round size: Seed $658k–$3M; Grant $80k–$165k
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- mo:re GmbH — We offer standardized tissue cultures and protocols to better predict drug responses and investigate disease models.
- Flexvelop — Flexvelop combines financial technology with circular economy to add innovative values to the core function of equipment funding.Local vendors and online-shops integrate Flexvelop as a seamless embedded payment option. Business customers are now able to #flex new equipment per click right at the point of sale. Insurance is already covered, andour customers have now the weekly option, to buy- or return their equipment, easily. This enables a new world of worry-free and flexible business growth.We #flex business equipment from €300 up to €20.000 per item; e.g. coffee-machines, laptops, gym- or dental-equipment,... anything you need for your business.NEXT GENERATION PAYMENTS + Technological Innovation: fully automatic embedded payment option + Economical Innovation: optionality (rent/buy/return) + insurance included + Ecological Innovation: sustainability (contributing to a circular economy) = Enabling worry-free flexible business developmentForget renting. Forget leasing. Grow smart - flex it!
- eleQtron — eleQtron creates and operates quantum computers based on trapped ions, radio frequency control, and Magnetic Gradient Induced Coupling (MAGIC). It also puts forward novel ideas for scalable quantum processors based on RF-controlled trapped ions. eleQtron will run MAGIC quantum computers and provide quantum computing performance on a subscriptionbasis.
Born2Grow is a german venture fund focusing on early stage investments. They invest up to 500k€ in innovative business models. They are based in Heilbronn in Baden-Wuerttemberg. Born2Grow focus on investments lies within the MedTech, BioTech, FinTech area as well as some other online industries
Show more...Investment focus
- Industry: Software, Medical, Health Care
- Stage:Seed, Series A, Series B
- Geography: Germany, Finland, United States
Investor stats
- Total investments: 23
- Round size: Seed $1.1M–$3.3M; Series A $3M–$3.3M; Series B $1.1M–$3.3M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Semorai — The SEMORAI Engineering AI Suite is your App Store for AI agents for reliable support in demanding mechanical engineering. Connect comprehensive engineering knowledge with your company know-how to accelerate your processes through AI to an unprecedented degree.
- Doinstruct — Doinstruct offers mobile training solution for frontline workers.
- traplinked — Digitale Fallensysteme - Endlich wissen, was los ist! Mit den traplinked Sensormodulen JERRY und TOM erhalten Sie in Echtzeit ein digitales Abbild Ihrer Kontrollpunkte.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 298
- Round size: Series A $6M–$65M; Series B $10M–$102M; Series C $11M–$100M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- protera — Protera is advancing the science of protein engineering to address some of the most critical problems and opportunities in food, agriculture, the environment and human health. We streamline protein design and development with MADI, our proprietary deep learning algorithm, to predict high value protein products and enzymes with unprecedented speed.Our in-house lab generates small quantities of the new predicted structures to validate their desired performance. Upon lab validation, we collaborate with our clients on next steps to move from pilot to industrial scale production.
- Bioptimus — Our mission is to build the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.
- T-Therapeutics — T-Therapeutics is a expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration. .
Think.Health invests as a boutique risk-taker in healthcare ventures. We continuously seek innovations and disruptive business models in digital healthcare, medical technologies and health service providers,
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Series A, Series B
- Geography: Germany, United States, France
Investor stats
- Total investments: 34
- Round size: Seed $1.1M–$8.7M; Series A $3.6M–$28M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
- Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.
- Sphingotec GmbH — Improving patient outcomes with innovative diagnostics for critical care: Actionable insights in real-time
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Sparkasse Jena is a German savings bank offers a collection of financial products and services to private, retail, and corporate customers.
Show more...Investment focus
- Industry: Medical, Health Care, Shopping
- Stage:Seed, Series A, Series C
- Geography: Germany, United States
Investor stats
- Total investments: 7
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- NovaPump — The NovaPump GmbH is a cardiology company based in Jena/Germany devoloping cutting-edge therapeutical solutions in the field of non-invasive and percutaneous circulation support. The so called PERKAT (PERKutane KATheterpumpe) technique will be offered as pLVAD & pRVAD heart pumps for acute left or right heart patients within the nextyears. PERKAT works together with the current IABP technique (intra aortic balloon pump with about 200,000 cases p.a. internationally) and is the only-one catheter-based & self-expanding, pulsatile & ECG-triggered, cost-effective heart pump technique with a high pump performance. PERKAT is not available on the market so far. Articles in leading scientific journals and presentations at the top four international cardiology conferences in the last years show the medical need, the development status and the technological and medical advantages of PERKAT.
- PERCEPTEC — PERCEPTEC is an application-oriented think tank with the aim of accelerating the process of modernization and digitalization of the optometric and ophthalmological sector.
- DeepEn — DeepEn is a research transfer start-up from Leibniz Institute of Photonic Technologies. It focus on the development of solutions in the field of fibrephotonics, biophotonics and bioimaging.
Carma Fund is an early-stage investment fund for advancing life science and healthcare technologies.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Series A, Series B
- Geography: Germany, France, Sweden
Investor stats
- Total investments: 12
- Round size: Seed $2.7M–$13M; Series A $4.4M–$12M; Series B $34M–$62M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Kupando — Kupando is a biopharmaceutical company that develops agonists to stimulates innate immunity.
- Allogenetics — Allogenetics GmbH provides a unique solution to the problem of organ rejection following transplantation. It is a distinct first-in-class therapy since it addresses the transplant rather than paralyzing the patient's immune system.
- Heidelberg Epignostix — Heidelberg Epignostix is a pioneering start-up led by a dedicated team of DNA methylation-based tumor categorization experts. Heidelberg Epignostix has revolutionized tumor categorization by using the strength of methylation-based algorithms.
Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 185
- Lead/follow: no public data
Portfolio highlights
- Aignostics — Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of preciseheatmaps and image overlays. These heatmaps allow pathologists to quickly verify the results of the AI, which is crucial, as the pathologist is ultimately responsible for the diagnosis.The company was founded in 2018 and is headquartered in Berlin, Germany.
- Sphingotec GmbH — Improving patient outcomes with innovative diagnostics for critical care: Actionable insights in real-time
- CorFlow Therapeutics — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
The Bertelsmann Investments division pools Bertelsmann's holdings in startups around the world.
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: Germany, United States, Israel
Investor stats
- Total investments: 16
- Round size: Seed $3M–$3.3M; Series A $10M–$20M; Series B $7.2M–$33M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- AppLike — AppLike develops apps for all mobile devices and provides mobile advertising, app recommendation, and innovative B2B solutions. The company was founded in 2015 and is headquartered in Hamburg, Germany.
- Teton — The future of contactless patient monitoring to prevent exacerbation
- Birches Health — Discover Birches Health, a specialized provider of online therapy for gambling addiction and other compulsive behaviors. Start recovery today with expert online counseling covered by insurance.
Kapitalbeteiligungsgesellschaft der Kreissparkasse Esslingen-Nürtingen mbH
Show more...Investment focus
- Industry: Software, EdTech, Medical
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany
Investor stats
- Total investments: 6
- Round size: Seed $1.2M–$1.6M; Series A $10M–$30M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- gyde — Gyde offers digital micro-learning and cross-company coaching for managers.
- VISPA — Your virtual unlimited space for innovation projects, workshop facilitation, and agile meetings. With more than 30 available pre-built templates.
- NVision Imaging Technologies — NVision Imaging Technologies is leveraging advances in quantum physics to enable the first routine, convenient and affordable use of Magnetic Resonance Imaging (MRI) for assessing early patient response to cancer treatment at the metabolic level.
APEX Ventures is an early-stage venture capital fund that invests in start-ups grounded in unique and protectable technology. They provide support and resources and aims to develop their start-ups in their respective field. Their initial focus areas include digital media, business intelligence, cybersecurity, fintech, and the future of work.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United Kingdom, Austria
Investor stats
- Total investments: 57
- Round size: Seed $1.3M–$8M; Pre-Seed $511k–$3M; Series A $5.2M–$28M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
- Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
- OroraTech — From safeguarding forests and ecosystems to protecting communities and critical assets, OroraTech's advanced technology and reliable insights address challenges, mitigate risks, and drive meaningful impact.
Atlantic Labs supports and invests in mission-driven founders working on transformative technology ventures. <br><br>We partner with founders early, providing the capital, tools and network necessary to growing their companies and accompanying them on their entrepreneurial journey. We are currently active in areas including Digital Health, Future of Work, Machine Learning, Decentralized Networks, Mobility and Industrial Applications.
Show more...Investment focus
- Industry: Software, Health Care, Financial Services
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 194
- Round size: Seed $1.2M–$9.1M; Pre-Seed $850k–$3.8M; Series A $4.6M–$32M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Cluno — Cluno is an online car subscription service providing rental cars irrespective of any contracts. Cluno's digital car subscription challenges traditional car ownership models in the mobility market and expands the space between hourly and years-long commitments with a flexible option and transparent, fully predictable costs. The carsubscription is offered at a monthly package price, which covers almost all car-related costs such as maintenance, wear and tear, seasonal tires, warranty, registration, vehicle tax, insurance, and vehicle inspections. The minimum booking period is six months per vehicle. Subject to a notice period of three months, customers can change their vehicle after the minimum period, pause their car subscription, or continue on with their Cluno car indefinitely.
- bonify — Bonify, a Berlin based FinTech-Start-up, enables customers to benefit from their credit scoring and financial data. The company gives customers free and easy access to their credit score and let them upload additional relevant data. Then, it offers tools and personalized recommendations to help optimize the customer’s financial situation.Foundedin 2015 by key executives of McKinsey and Zalando, bonify has received significant funding from internationally leading VCs and successful entrepreneurs.
- tozero — Truly bringing lithium-ion battery waste tozero by recovering all critical matierlas, like lithium, nickel, cobalt, manganese, and graphite.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Innovative post-revenue startups with first customers trust us as highly reliable investors. We have been an active player in the venture capital market for over 25 years. Due to our evergreen approach, we offer institutional venture capital without the limitations of the usual fund structure. Predominantly we invest straight equity. Additionally,we can offer venture debt to mature startups close to break-even in order to avoid further dilution for founders. Being a private investment company we act as both lead investor or co-investor. We can also fulfill the private lead investor role for public investors like Bayern Kapital. Together we are increasing YOUR company's value.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Series A, Series B
- Geography: Germany, Italy, United States
Investor stats
- Total investments: 115
- Round size: Series A $428k–$23M; Series B $732k–$10M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- tado° — Tado° is The Heating App for private homes and small businesses. It adjusts to the residents' behavior in real time and also takes current weather forecasts and building characteristics into account. tado° GmbH is a Munich based Tech Startup bringing Internet of Things into the Cleantech Market. It was founded by Christian Deilmann, JohannesSchwarz, Valentin Sawadski and Leopold von Bismarck in 2011. A team of qualified young professionals has been working on the development of tado° for approximately two years in Munich.
- IDnow — IDnow provides advanced machine-learning technology for its Identity-as-a-Service platform that can verify identities in real time. The company's solutions guarantee legal security throughout Europe and the highest level of data security. The company provides a legally secure solution without additional hardware in the area of videoidentification of customers and electronic signatures.The company's offer is directed at all business customers who would like to provide customer identification and contract conclusion online, such as banks, telecommunications companies, Fintechs, etc. Its customer portfolio includes renowned firms such as Commerzbank, UBS, Sixt neuwagen, Telefónica, and N26.IDnow was founded on 2014 and is headquartered in Munich, Germany.
- StoryBox — StoryBox provides a Software as a Service solution for businesses to create, share and structure video content to make it searchable. With the system, companies can create and organize smartphone-based videos for any application scenario. Using the app, videos can be created and shared by every employee using templates. The app suggests picturesettings and scene lengths automatically and offers an automated creation which includes corporate design. The content can be stored in the DSGVO-compliant StoryBox cloud and can be accessed, filtered and analyzed from anywhere. Customers include Iveco, Erste Group, Evonik, Alten, and KTM.
Seed Fonds has a strong competence network with national and international investors, business angels & expertes from the industry. They are specialized in the development of comprehensive financing models offering stability and development opportunities on the long term.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Seed, Series A
- Geography: Germany
Investor stats
- Total investments: 8
- Round size: Series A $2.2M–$6M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- miacosa — miacosa.de is operated by the Endorsed Goods GmbH. miacosa.de is a social shopping concept from Germany based in Cologne. Social Shopping the miacosa way means that members select their personal shopping team of experts and celebrities that present products they love on miacosa.de Miacosa is for members only. The free service starts with productsfrom the fields of Health Style, Home & Living, Kitchen and fashion accessories.
- Hemovent — Based in Aachen, Germany, Hemovent is a privately held medical technology company that is developing a portable ECMO (Extra Corporeal Membrane Oxygenation) unit. Hemovent was founded by serial entrepreneur, Christof Lenz and Oliver Marseille, inventors of the company’s proprietary platform. It is the goal of the company to develop aninnovative solution, with precision and craftsmanship, that will aide patients with lung and heart function while allowing them to be mobile.
- aquila biolabs — aquila biolabs is a German technology company focusing on the development of innovative laboratory devices for the analysis of shake-flask fermentations in biotechnological, chemical and pharmaceutical research and development.
Munich-based AQAL Group is an active technology and impact holding company using the Integral Investing approach. Focus: exponential technology and digital evolution (Internet infrastructure, artificial intelligence, blockchain & financial tech, B2B IT solutions, Industry 4.0), green technology (renewable energy, energy efficiency, cleantech, circular economy), and life in the 21st century (future mobility, food, life science, med tech, media & entertainment tech).
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Pre-Seed
- Geography: Germany, United States
Investor stats
- Total investments: 11
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- DNTOX — We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, itis supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want to realize our company vision: Safe chemicals without animal experiments!
- wondder — Empowering People through Virtual Reality Use our training in Virtual Reality to create more happy, successful, productive teams. Experience the power of wondder. Contact Us Empowering People through Virtual Reality Use our training in Virtual Reality to create more happy,
- Elona Health — Elona Health creates digital solutions that shape tomorrow's psychotherapy and support patients and therapists alike.
TruVenturo is an entrepreneurial investor and company builder in Europe and the United States
Show more...Investment focus
- Industry: Travel, Tourism, Software
- Stage:Seed, Series A
- Geography: Germany, United States, Spain
Investor stats
- Total investments: 19
- Round size: Seed $1.1M–$26M; Series A $2.4M–$18M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Rune Labs — Software and data platform for neuromodulation
- get.me — get.me connects social media accounts or links to sites. They create a free link in their bio page that earns money and turns followers into paying subscribers, so they earn money from social media with every subscriber.
- Tomorrow Bio — At Tomorrow Bio, we use the latest technology to preserve you for however long it takes until medical technology can extend your life.
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 94
- Round size: Seed $1.3M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- Perfood — Perfood is a digital therapeutic startup that identifies what actions need to take on a personalized level, to prevent or fight diseases. Using sensors, lab results, and holistic analyses, they derive therapeutic angles and deliver them in a slick, easy-to-use way, making them accessible for all patients. They call this approach digitaltherapeutics. A digital solution that is just as effective as a drug. But without side effects.
- Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
- Rinri Therapeutics — Rinri Therapeutics has been founded on pioneering research into auditory stem cells led by Professor Marcelo Rivolta at the University of Sheffield.
Birds of a feather flock together? Not our style! We promote healthcare startups who believe in their vision and want to be a success at it. DocCheck Guano is a hatchery for precocial birds aiming to land in the market. We provide the ideal fertiliser for startups: capital, know-how, market access and network. Oh, and our focus is on seed funding.
Show more...Investment focus
- Industry: Health Care, Medical, Mobile Apps
- Stage:Seed, Pre-Seed
- Geography: Germany, Spain, The Netherlands
Investor stats
- Total investments: 8
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Amparo — We empower amputees so they can live life to the full. Amparo is a developer, manufacturer and distributor of prosthetic components. It developed the Confidence Socket, which is the interface between the patient's residual limb and the prosthetic leg itself. 1) The fitting process is as fast as 1h time; 2) The material can be remolded 10times, saving huge costs of health providers; and 3) All tools fit into a sports bag. making it possible to service amputee anywhere in the world.
- medflex — Entdecken Sie medflex: Automatisierte Patientenkommunikation mit unserem KI-Teammitglied. Jetzt mehr erfahren!
- Mammoth Hunters — Mammoth Hunters is a 360° wellness solution offering accessible functional training, natural nutrition and lifestyle advice packaged as a mobile/web based SaaS. The founders come from a scientific background and use discoveries in human physiology and evolution to create personalized fitness journeys. The program is designed toeliminate all barriers that prevent people from leading a healthy lifestyle - lack of time, knowledge and motivation. The company employs 12+ people in Barcelona Spain and has key partnerships with fitness experts, healthcare companies, and sports technology companies.
With decorative, high-quality and sustainable plastic products, we create clear added value for our customers and improve the quality of life.
Show more...Investment focus
- Industry: Health Care, Medical Device, 3D Printing
- Stage:Series A
- Geography: Germany
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Kumovis — The EXT 220 MED, formerly the Kumovis R1, is the only extrusion platform that features an integrated clean room and is validated by leading medical device manufacturers and hospitals worldwide.
- Inovedis — The SINEFIX Implant System is an easy-to-learn solution aimed at simplifying rotator cuff repair procedures and improving patient outcomes.
We are a team of former serial founders managing $1.5Bn across a number of funds, with offices in Tel Aviv, London, and New York. We back the next generation of category-defining companies with conviction of founders who have built companies themselves.We back founders with a partnership built on trust, fairness and real operating experience. Westand with founders through every challenge, and help them grow with clarity, resilience and purpose.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 248
- Round size: Seed $1.4M–$13M; Series A $4M–$24M; Series B $14M–$55M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $300M in 2022
Portfolio highlights
- re:cap — re:cap enables companies in the subscription economy to trade future revenues for on-demand, non-dilutive capital. Fast, transparent and easy.
- Classiq Technologies — A software platform that helps users create scalable complex quantum computer algorithms, software, and circuits for any gate-based quantum computer
- Packfleet — We serve millions of Londoners, combining a top-notch delivery service with advanced technology to offer a carbon-neutral delivery experience like no other.
Asabys Partners is a venture capital firm that invests across the board in human healthcare. The company is active in the health-tech and biopharma industries and aims to invest in Spain and abroad in innovative and transformative technologies. Asabys Partners are motivated by the idea of pushing the boundaries of science and medicine. This is donethrough the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B, Seed
- Geography: Spain, France, Belgium
Investor stats
- Total investments: 35
- Round size: Seed $1.2M–$13M; Series A $7M–$55M; Series B $19M–$55M
- Lead/follow: 54% lead, 46% follow
- Last fund: Likely still investing — raised $117M in 2022
Portfolio highlights
- Qida — Qida is a trusted company in the health and social sector that selects the best caregivers for the elderly and / or dependent.
- DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
- Augustine Therapeutics — Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover our pipeline poised for clinical impact.
TQ Group is one of the leading technology companies in the electronics industry, offering a complete range of services
Show more...Investment focus
- Industry: Sports, Hardware, Robotics
- Stage:Seed, Series A, Series B
- Geography: Germany
Investor stats
- Total investments: 7
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- enna — enna is the window to the digital world for people who have problems using smartphones or tablets
- Mellow Boards — Mellow Boards designs and manufactures electric drive system that could fit on skateboards. Unlike all other offers on the market, within minutes Mellow can pimp your favorite board into a high-quality e-board with a top speed of 40km/h ( 25mph).The product was launch in Kickstarter and reached a funding of more than 100 thousand Euros.Founded in 2015, Mellow is based in Hamburg, Germany.
- Reactive Robotics — Reactive Robotics was founded as a GmbH in Munich, Germany, in April 2015. Their team has a combined 12 years of rehabilitation robotics research, vast startup experience and a large clinical network to bring this device to life. They are proud to feature an excellent array of supporters that provide advice on every level required for thesuccessful start-up of a medical technology company. Confirmed advisors provide access to patients, support them in engineering, on legal issues and when dealing with the details of registering a medical device with the authorities.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Lauder Partners, LLC is an entity investing in various realms of the technology field. Lauder invest both directly in companies as well as in funds - both venture and others. Since it primarily invests the capital of Gary Lauder and family members, we don't provide much information to the public.
Show more...Investment focus
- Industry: Software, Internet, Health Care
- Stage:Series B, Seed
- Geography: United States, United Kingdom, China
Investor stats
- Total investments: 99
- Round size: Seed $300k–$15M; Series B $9.4M–$50M
- Lead/follow: 1% lead, 99% follow
- Last fund: May invest from a new fund soon — last raise in 1986
Portfolio highlights
- Radia — Radia is building the world's largest aircraft, the WindRunner
- Lassen Peak — PUBLIC SAFETY INNOVATION Threat detection for a safer world Once in a great while, the path of advanced technology unexpectedly joins the basic needs of society. Learn More https://www.lassenpeak.com/wp-content/uploads/2023/12/Globe3.m4v Linkedin Envelope
- NVision Imaging Technologies — NVision Imaging Technologies is leveraging advances in quantum physics to enable the first routine, convenient and affordable use of Magnetic Resonance Imaging (MRI) for assessing early patient response to cancer treatment at the metabolic level.
M- Invest GmbH, Singen, Germany, represents the holding company for the business shares and stakes held by the Meder family.
Show more...Investment focus
- Industry: Medical Device, Medical, Software
- Stage:Series A
- Geography: Germany
Investor stats
- Total investments: 3
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- CorTec — Reliable products for active implantable device development. We realize your next project with you and offer individual solutions that meet your specific requirements for Medical Devices, especially in neurotechnology.
- Capical GmbH — Capical is your partner for target-oriented, fast and sophisticated integration of monitoring solutions in your product. We work in the fields of research, development and productive applications for contact-free ECG measurement for more than 10 years. During that time, we have established Capical as the worldwide leader of the capacitive electrodetechnology.Our offer covers all stages of the development process. With the target to provide innovative and successful products in collaboration with you, we support you from building first prototypes up till serial production. Your benefit is our extensive know-how and experience from projects in various industry sectors.Capical has been awarded with the Fresenius Inventor Award, the IHK Technology Transfer Award and additional awards for its capability to transfer the capacitive technology in marketable products. It has been the first company worldwide which has medically approved an ECG-device based on capacitive electrodes and we are capable to defend your and our interests against competitors due to own important property rights.Join us with our target to establish the capacitive ECG measurement in various market segments to improve the quality of life of elderly or ill persons as well as improve safety and comfort in the increasing segment of automated driving.
Startseite von Winning Mindset Ventures
Show more...Investment focus
- Industry: Medical, Software, Consulting
- Stage:Series A
- Geography: Germany
Investor stats
- Total investments: 3
- Round size: Series A $13M–$13M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- deepc — The Radiology AI Platform - Your effortless access to AI
- XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
B2venture is a venture capital firm focused on early-stage investments in digital and industrial technology companies. B2venture invests EUR 100m+ per year in high-growth companies with ticket sizes from EUR 0.25m to 3.5m.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Germany, Switzerland, United Kingdom
Investor stats
- Total investments: 222
- Round size: Seed $1.3M–$9M; Series A $4M–$22M; Series B $8M–$52M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely still investing — raised $135M in 2021
Portfolio highlights
- Orus Energy — Orus Energy leverages the power of AI to unlock potential of electrical flexibility in commercial buildings.
- Seven Senders — Excellent international delivery is a competitive advantage. Connect with Seven Senders and benefit. Find out more now!
- Sitegeist —
VF-Funds for innovative and scalable start-ups from the Rhineland Area, Germany
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Spain
Investor stats
- Total investments: 29
- Round size: Seed $2.5M–$5.4M; Series A $5.5M–$28M
- Lead/follow: 66% lead, 34% follow
Portfolio highlights
- Eeden — Eeden engages in the manufacture and supply of textiles.
- Planted Green — Planted Green plants mixed forests to compensate for CO2 emissions.
- specter automation — Construction is the second least digitized sector in the world with 96% of all data being unused. Although detailed planning data is created upfront, a lack of suitable digital tools prevents its transfer to the construction site. SPECTER’s web-based construction management software uniquely incorporates the core components of constructionplanning, reducing the organizational burden on construction management and helping to meet project timelines and budgets.
Green Park & Golf, built on over 50 years of operational and financial experience, seeks investment opportunities that offer above-market returns for its investors. Led by Clay Heighten, M.D., and Carl Soderstrom, the Firm delivers strategic solutions, financial backing and a reliable network to its portfolio companies. The Dallas-based Firm iscurrently looking for investment opportunities in medical-related start-ups.Dr. Heighten founded MedicalEdge Healthcare Group in 1993, and Mr. Soderstrom started PhyServe Physician Services in 1998 to administer the financial and operational needs of MedicalEdge. Together, the companies managed over 550 providers in five major markets. In 2011, the companies were sold to Texas Health Resources, a $3.8 billion health care system. That’s when Green Park & Golf was born.After earning his MBA at Southern Methodist University, Mr. Garcia joined them full-time in May 2011 to actively pursue new investment opportunities and monitor other investments in their portfolio. He has prior professional experience at FedEx, Bold Ventures, and Lone Star Investment Advisors.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: United States, Israel, Sweden
Investor stats
- Total investments: 93
- Round size: Seed $420k–$3.2M; Series A $1.3M–$18M; Series B $2.1M–$45M
- Lead/follow: 13% lead, 87% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- Vellum Health — Vellum Health platform provides on-demand IV enablement & treatment optimized for provider organizations, payers, clinicians, and patients.
- Affineon Health — Affineon is the AI inbox that saves provider time. We automatically handle normal and clinically insignificant lab results, and help providers get through abnormal lab results faster. Our AI automatically groups, analyzes, and trends lab results into a smart summary, including possible next steps and a complete patient note. We also route"noise" to staff, reducing the number of messages a physician needs to pay attention to by up to 30%. The result is 5+ hours saved per week per provider. Plus, Affineon tightly integrates with the EHR, so providers don’t need to change their existing workflow.
- Mobia Medical — MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases. Its therapies include paired vagus nerve stimulation system (Paired VNS System) and wireless neurostimulation system for the treatment of chronic pain, post-stroke upper limb mobility issues, and variousneurological indications that enable healthcare practitioners to treat post-stroke upper limb mobility issues.Founded in 2007, MicroTransponder is headquartered in Dallas, Texas.
We back ambitious HealthTech founders solving complex healthcare challenges. We provide capital, deep sector expertise, and hands-on support to build global champions.
Show more...Investment focus
- Industry: Health Care, Software, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, Poland, United Kingdom
Investor stats
- Total investments: 28
- Round size: Seed $1.1M–$5.3M; Pre-Seed $764k–$2.5M; Series A $10M–$48M
- Lead/follow: 68% lead, 32% follow
- Last fund: Likely still investing — raised $70M in 2022
Portfolio highlights
- dehaze — dehaze provides healthcare services by bringing medical AI models into clinical practice.
- Vetnio — Vetnio is an AI scribe that records conversations between veterinary professionals and pet owners, automatically generating clinical notes for the meetings. It saves veterinary professionals time, allowing them to focus more on their patients.
- Caire — The Future of health measurements is contactless
IBG Beteiligungsgesellschaft Sachsen-Anhalt is a venture capital firm makes investments in territories such as Germany and Denmark.
Show more...Investment focus
- Industry: Software, Electronics, Manufacturing
- Stage:Seed, Series A
- Geography: Germany, Austria
Investor stats
- Total investments: 15
- Round size: Seed $1.3M–$3M; Series A $4.4M–$5.9M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- RAYDIAX — We are Raydiax.Interventional only.Our goal is to reinvent computer tomography that is focussed on treatment.
- Solar Materials — SOLAR MATERIALS developed a recycling technology for solar modules, which recovers all raw materials for a circular solar industry.
- PerioTrap Pharmaceuticals GmbH — PerioTrap is an early stage biopharmaceutical company that aims to eradicate the root cause of periodontitis
Grönemeyer Swiss Health is focussing on Investments in innovative companies in the Health Care sector and also provides services for the distribution of products.
Show more...Investment focus
- Industry: Medical, Manufacturing, Medical Device
- Stage:Series A
- Geography: Germany
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Atlas Medical Technologies — Atlas Medical Technologies is a manufacturing company that develops navigation systems for medical doctors for radiology and orthopedics.
Founded in 2015, dRx Capital is Novartis' Digital Health Venture Fund investing in entrepreneurs transforming healthcare through data and digital technology. The fund invests in technology platforms improving access to healthcare and reimagining the practice of medicine, with a focus on AI & ML, big data, R&D optimization, patientcare, and pharma supply chain and commercialization.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series C, Series A
- Geography: United States, Germany, United Kingdom
Investor stats
- Total investments: 32
- Round size: Series A $3M–$40M; Series B $15M–$160M; Series C $21M–$100M
- Lead/follow: 13% lead, 87% follow
- Last fund: May invest from a new fund soon — raised $100M in 2015
Portfolio highlights
- Koneksa Health — Koneksa Health is a healthcare data analytics company that helps researchers incorporate emerging technologies (bio-sensors, activity trackers, mobile-based questionnaires, etc.) into their clinical studies. Their Koneksa Compare software dashboard enables the collection, visualization, and analysis of these patient-generated data sets.Koneksacurrently supports academic and life sciences researchers, expands the universe of data that can be analyzed while also removing subjective characteristics from clinical endpoints. It was founded in 2013 and is based in New York, United States.
- Pear Therapeutics — Pioneer in Prescription Digital Therapeutics (PDTs) with the goal of providing better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers.
- Peptone — We are the first in class pre-clinical translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered targets.
Medical Device VC funding in Germany at a glance
Stats across 250 deals from 265 investors.
Access all 265 VC funds in Germany Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device VC Funds in Germany investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 265 VC funds investing in Germany Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!